Finanzielle Vergleiche Vericel Corporation

Aktien

A12FU4

US92346J1088

VCEL

Pharmazeutika

Markt geschlossen - Nasdaq 22:00:00 15.12.2025 % 5 Tage Veränd. 1. Jan.
36.49 USD -0.14% Intraday Chart für Vericel Corporation -2.17% -33.55%
Hauptkonkurrenten
Umsatz (N-1) Nettogewinn (N-1) EBIT-Marge (N-1) ROE (N-1) ROA (N-1) Verschuldungsgrad (N-1)
237 Mio. 4.37%1.9% - - -
14.2 Mrd. 31.07%36.7%19.23%15.02%-1.11x
15.56 Mrd. 19.3%28.72%16.36%7.75%1.74x
3.08 Mrd. 23.82%29.03%10.45%6.49%0.1x
6.37 Mrd. 17.31%13.59%11.21%6.48%0.99x
9.68 Mrd. 16.87%31.16%10.36%5.95%1.06x
1.29 Mrd. -1%-8.02%-0.74%-0.45%-11.4x
4.24 Mrd. 0.77%9.76%5.27%3.72%-4.29x
69.63 Mio. 59.01%24.7%28.77%18.72%-6.16x
222 Mio. -241.44%-267.22%35.11%-73.11%-1.77x
681 Mio. -10.97%-17.14%-8.58%-7.13%8.63x
2.35 Mrd. 14.93%22.42%10.9%5.41%1.59x
3.24 Mrd. -110.04%-121.91%-28.77%-21.87%1.87x
10.9 Mio. -2’957.71%-3’477.43%-33.47% - 3.99x
2.85 Mrd. 14.96%16.97%8.05%6.17%-0.93x
1.25 Mrd. 22.95%28.06%14.19%8.74%0.28x
308 Mio. 4.73%4.18%0.85% - -5.29x
7.47 Mrd. 2.18%18.81%2.79%0.74%5.16x
386 Mio. -74.47%-72.74%-231.63%-49.66%0.49x
Durchschnitt 3.87 Mrd. -166.49% -194.66% -7.2% -4.19% -0.28x
Gewichteter Durchschnitt nach Marktkapitalisierung 7.08 Mrd. -69.3% -80.93% 6.44% 3.09% -0.27x
Biopharmazeutika